ClinicalTrials.Veeva

Menu

Reducing Dementia Risk With Digital Health Coaching (DC-MARVEL)

N

Neurotrack Technologies

Status

Unknown

Conditions

Alzheimer Disease
Mild Cognitive Impairment
Cognitive Decline
Dementia

Treatments

Behavioral: MindMate + Health Coaching
Other: Health Education

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT04559789
1R44AG063672-01
R44AG063672 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The Digital Cognitive Multi-domain Alzheimer's Risk Velocity (DC MARVEL) study is a 2-year randomized controlled trial on dementia prevention. The purpose of this study is to determine the effect of a digital cognitive health program on dementia risk, cognitive function, and general health outcomes in middle age to older adults compared to a control group that receives health education.

Full description

Alzheimer's Disease (AD) is expected to affect 131 million people worldwide by 2050, but as many as 40% of these cases may be prevented by targeting modifiable risk factors such as diet, physical activity, cognitive engagement, and smoking. Neurotrack Technologies, Inc. will test the efficacy of a digital multi-domain lifestyle intervention with health coaching for cognitive health designed to change behaviors associated with increased risk for AD. This digital intervention addresses the challenge of scaling effective multi-domain lifestyle interventions for cognitive health and has the potential to improve risk behaviors, thereby reducing and/or delaying cognitive decline in older adults at risk for AD.

Enrollment

200 patients

Sex

All

Ages

45 to 75 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 45-75
  • BMI 18.5 - 39.9 kg/m2
  • Fluent in English (written and spoken)
  • A minimum of 2 of the following risk factors for AD from ANU-ADRI: High school education or less; Overweight, or class I or class II obese (BMI 25-39.9 kg/m2); History of diabetes; History of hypertension; History of high cholesterol; History of smoking; History of traumatic brain injury
  • Maximum of 1 of the following protective factors for AD from ANU-ADRI: High level of physical activity; High fish consumption; High level of cognitive engagement
  • Ability to send and receive text messages
  • Own a smartphone, have a reliable internet connection, and willing to use email
  • Ability to participate in light to moderate physical activity
  • Willingness to be randomized

Exclusion criteria

  • Physician diagnosis of: mental health condition (e.g., eating disorder, alcohol/substance use, schizophrenia, etc.); neurologic conditions (e.g. epilepsy, stroke, multiple sclerosis, Parkinson's disease, brain tumor, or severe traumatic brain injury); dementia, probable dementia, or mild cognitive impairment; other significant health condition (e.g. congestive heart failure, chronic obstructive pulmonary disease, coronary artery disease, renal failure, chronic kidney disease, pulmonary hypertension)
  • Recent cardiovascular event or recent treatment for cancer (within the last year); on dialysis; or on active organ transplant list
  • Visual problems that prevent viewing screen at a normal distance (e.g., legal blindness, detached retina, occlusive cataracts)
  • History of learning disability
  • Currently participating in a formal cognitive training coaching program or other lifestyle change program (e.g. diabetes prevention program)
  • Currently pregnant or planning on becoming pregnant in the next two years

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

200 participants in 2 patient groups

Digital Lifestyle Intervention
Experimental group
Description:
Participants randomized to the intervention arm will receive access to a digital intervention consisting of the MindMate cognitive health app and Neurotrack's personalized health coaching platform.
Treatment:
Behavioral: MindMate + Health Coaching
Health Education
Active Comparator group
Description:
Participants randomized to the control arm will receive digital health education materials that mirror the content in the app.
Treatment:
Other: Health Education

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems